1Gunduz N,Fisher B,Saffer BA.Effect of surgical removal on thegrowth and kinetics of residual tumor[J].Cancer Res,1979,39(11):3891-3895.
2Konecny GE,Pegram MD,Venkatesan N. Activity of the dual kinase inhibitor lapatinib (GW572016) against HER-2-overexpressing and trastuzumab-treated breast cancer cells[J].{H}Cancer Research,2006,(3):1630.
3Yarden Y,Baselga J,MilesD.Molecularapproach to breast cancer treatment[J].Semin Oncol, 2004,31 : 6-13.
4Esteva FJ. Monoclonal antibodies, small molecules, and vaccines in the treatment ofbreast cancer[J].Oncologist, 2004,9: 4-9.
5Jahanzeb M.Trastuzumab -Based Combinations in Metastatic Breast Cancer:How to Make a Choice [J].Clinical Breast Cancer, 2003,1:28-38.
